625 related articles for article (PubMed ID: 12008777)
1. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
Hulley S
Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
5. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
McPherson R
Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
[TBL] [Abstract][Full Text] [Related]
6. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
7. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
8. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
9. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
Leiter LA
Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
[TBL] [Abstract][Full Text] [Related]
10. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
11. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of estrogens and progestogens and cardiovascular risk].
Boissel JP; Cornu C
Therapie; 1999; 54(3):387-92. PubMed ID: 10500456
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
Gaspard U
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
[TBL] [Abstract][Full Text] [Related]
18. HRT as secondary prevention of cardiovascular disease.
Ylikorkala O
Maturitas; 2004 Apr; 47(4):315-8. PubMed ID: 15063485
[TBL] [Abstract][Full Text] [Related]
19. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
